Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance

2025 ICD-10-CM code F13.282

Sedative, hypnotic, or anxiolytic dependence with sedative, hypnotic, or anxiolytic-induced sleep disorder.

Use this code when both a dependence on SHAs and an SHA-induced sleep disorder are present. If the sleep disorder is due to another cause, code the dependence and the sleep disorder separately. Do not use this code for SHA abuse or other SHA-induced disorders; use the appropriate code from the F13 category.

Medical necessity is established by demonstrating the patient's dependence on SHA and the presence of a sleep disorder causally linked to SHA use.This includes documenting the impact of the conditions on the patient's daily life and functioning. Justification for treatment should outline the chosen approach and its expected benefits.

Diagnosis is made through patient history, including personal and social behavior, coupled with a physical examination and assessment of signs and symptoms. A sleep study and evaluation based on DSM criteria may also be utilized.

In simple words: This diagnosis means a person is unable to stop using sedative, hypnotic, or anxiolytic drugs (like sleeping pills or anti-anxiety medication) and has developed disturbed sleep as a side effect of taking these drugs.

This code describes a condition where an individual is dependent on sedative, hypnotic, or anxiolytic (SHA) medications, experiencing disturbed sleep patterns as a direct result of SHA use.Dependence is characterized by tolerance (needing increasing amounts to achieve the same effect) and withdrawal symptoms upon cessation.The sleep disorder is induced by the use of these medications and not caused by another factor.

Example 1: A patient presents with chronic insomnia and anxiety. They admit to taking increasingly higher doses of prescribed sleeping pills (e.g., zolpidem) to fall asleep and experience anxiety and difficulty sleeping when they try to reduce the dosage., A patient seeking treatment for substance abuse reports long-term use of benzodiazepines (e.g., lorazepam).They describe frequently waking up during the night and experiencing daytime sleepiness. They have tried to stop taking the medication but experienced severe withdrawal symptoms, including insomnia and increased anxiety, leading them to resume use., An individual is admitted to the hospital for detoxification. They have a history of dependence on barbiturates and report significant difficulty falling asleep and staying asleep, even when not taking the drugs. After a period of medically supervised withdrawal, their sleep patterns gradually improve.

Documentation should include the type of sedative, hypnotic, or anxiolytic used, the severity of the dependence, any other co-occurring conditions, and the patient's remission status (if applicable). Details of sleep disturbances should be documented, including frequency, duration, and associated symptoms.Supporting evidence such as sleep study results and DSM-based assessments should also be included.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.